f**********r
发帖数: 18251 | 1 Immunologist (Seattle)
Etubics Corporation is a bio-pharmaceutical company with a proprietary
vaccine
platform the Etubics Platform, which is stealth to the immune system and has
the ability
to deliver a long lasting "active" immune response against cancer and
infectious
disease targets. We are looking to add a Immunologist to our research and
development team. The successful candidate must have a Ph.D. in Immunology,
Microbiology, Molecular biology or similar. This is a full-time, salaried
position with
benefits.
Job Summary
Perform laboratory and investigative procedures utilizing a variety of
routine
immunologic experimental techniques such as FACS, ELISpot, ELISA and cell
culture.
Incumbents have responsibility for research experiments and data integrity,
as assigned
by management. Collect, verify, record, and compile data and information in
support of
research.
Scope of Work
• Perform laboratory research experiments by performing various
investigative
procedures and operating a variety of instruments and other scientific
equipment.
These include FACS, ELISpot, and ELISA.
• Collect, record, organize and verify the accuracy of data; perform
calculations,
data interpretation and prepare charts, graphs and reports. May use software
applications to assemble, manipulate and/or format data and test reports.
Preferred Qualifications
• Ph.D. in Immunology, Microbiology, Molecular biology or similar with
two years of
relevant experience in immunologic research or vaccine development.
• Experience working with immunologic techniques utilized in
immunology and
vaccine research, including ELISpot, FACS and ELISA.
• Excellent skills in collecting and analyzing data, trouble-shooting,
and accurately
maintaining laboratory notebooks required.
• Flexibility and the ability to work in a fast-paced, team-oriented
environment.
Additional Information
Please submit a cover letter and your CV to b**[email protected]. Please include
the job
title in the subject line.
About Etubics
Etubics Corporation, based in Seattle, Wash., is a clinical stage bio-
pharmaceutical
company, which has developed a proprietary platform technology consisting of
a next
generation Ad5 vector vaccine platform and a manufacturing E.C7 human cell
line,
collectively the Etubics Platform. Clinical work to date shows that the
Etubics Platform
overcomes problems associated with existing adenovirus vectors. The Etubics
Platform
can be used to efficiently and rapidly develop immunotherapeutic drugs and
preventive
vaccines for a wide range of infectious diseases and cancers. www.etubics.
com |
|
